Study calls for more randomized trials on e-cigarettes

NewsGuard 100/100 Score

E-cigarettes are a potential smoking cessation aid and they may also be able to lower the risk of nicotine dependency in high-risk groups. The available scientific evidence, however, remains insufficient. This is the conclusion reached by Dennis Nowak et al. from Munich in this issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111: 349-55).

The authors performed a systematic literature search for data on e-cigarettes' mechanism of action, their emissions, how they are seen by groups of potential users, their efficacy in smoking cessation, and their addiction potential. According to an international survey e-cigarettes were used by younger people, those with higher incomes, and heavier smokers in particular. Among e-cigarette users, 85% reported that they used them to stop smoking. According to repeat surveys in the U.K., the number of people who were aware of e-cigarettes doubled between 2010 and 2012, and the number of users increased four-fold. An online survey of e-cigarette users found that 74% of those asked had not smoked tobacco for at least several weeks since using e-cigarettes, and 70% reported reduced cigarette cravings. However, there is evidence that people who have never previously smoked also use e-cigarettes. The rates among Polish and US students, for example, were 3% and 9% respectively.

Only two controlled trials show e-cigarettes as having similar effects to nicotine replacement therapies as smoking cessation aids; these effects were almost independent of nicotine content. The authors call for more randomized trials to be conducted.

Source: Deutsches Aerzteblatt International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Integrating stop smoking support with lung cancer screening could save lives